Neodynamics

We hosted an event Wednesday the 15th of March with CEO Anna Eriksrud and CFO Aaron Wong on funding as is and to be.

Meet CEO Anna Eriksrud and CFO Aaron Wong who will elaborate on options to raise long-term capital to enable the commercialization of NeoNavia in the US. The event takes place Wednesday the 15th. of March 2.00 PM.

CEO Anna Eriksrud makes a short presentation of NeoDynamics and answers questions about the business in an interview in collaboration with Uddaaktier on Monday, February 20th at 7 p.m.

NeoDynamics had a very busy 2022 and ready to launch Neonavia in US - 2023.   Medtech company NeoDynamics got FDA approval for Neonavia in US early fall 2022 and they are now ready for full commercialization of NeoNavia in US - 2023.

NeoDynamics Full year report 2022 with all consolidated entities and the company secures financing for the launch of NeoNavia in the US.

NeoDynamics today announces that Jie Bao and Xiaojun Xu will step down from the Board of Directors as of 2023-02-14 based on a mutual agreement.

NeoDynamics Swedish Medtech company listed on First North GM - Sweden. This report covers NeoDynamics core product - NeoNavia and an introduction to needles biopsies. Our focus in this report, description of the US breast care market and potential for NeoNavia to address the unmet need.

NeoDynamics Swedish Medtech company listed on First North GM - Sweden. This report covers NeoDynamics core product - NeoNavia and an introduction to needles biopsies. Our focus in this report, description of the US breast care market and potential for NeoNavia to address the unmet need.

Listen to Dr Sarah Vinnicombe - Lead Breast Radiologist presenting the COMPULSE study from the BSBR (British Society of Breast Radiology). Interesting take-aways.

Welcome to this special Christmas edition of our BioSnack newsletter from HC Andersen Capital where we will try and give you insights and perspectives on the fascinating world of BioTech and Life Science investing – and perhaps try and spread a little bit of Christmas spirit. In this addition we have added a christmas wish list for BioTech and Life Science investors. On behalf of our BioTech and Life Science team, we hope you enjoy the reading!

HC Andersen Capital and Inderes have the pleasure of inviting you to a virtual seminar focusing on the First North and Spotlight listed growth companies in the Nordic region. The macroeconomic environment has been challenging in 2022, and we are now looking into 2023. Get an update on several growth companies and industries before year-end and ask your questions directly to the management.